drugset / Trial / NCT01082848

ARIpiprazole in Anorexia NErvosa

NCT01082848

Phase 3 Unknown 60 enrolled Juan A. Arnaiz
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evidence is lacking on the effects of different psychotropic drugs in the treatment of anorexia nervosa (AR). However, HVA levels seem to be elevated in this disease, therefore suggesting a role for drugs with a partial agonist profile on dopaminergic receptors. This is a pilot study assessing the effects of aripiprazole in teenagers with AR, compared with a placebo.

Timeline

Start
2010-03
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 10 mg

Indications